Log in to save to my catalogue

Computational drug repurposing against SARS-CoV-2 reveals plasma membrane cholesterol depletion as k...

Computational drug repurposing against SARS-CoV-2 reveals plasma membrane cholesterol depletion as k...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2665140023

Computational drug repurposing against SARS-CoV-2 reveals plasma membrane cholesterol depletion as key factor of antiviral drug activity

About this item

Full title

Computational drug repurposing against SARS-CoV-2 reveals plasma membrane cholesterol depletion as key factor of antiviral drug activity

Publisher

United States: Public Library of Science

Journal title

PLoS computational biology, 2022-04, Vol.18 (4), p.e1010021-e1010021

Language

English

Formats

Publication information

Publisher

United States: Public Library of Science

More information

Scope and Contents

Contents

Comparing SARS-CoV-2 infection-induced gene expression signatures to drug treatment-induced gene expression signatures is a promising bioinformatic tool to repurpose existing drugs against SARS-CoV-2. The general hypothesis of signature-based drug repurposing is that drugs with inverse similarity to a disease signature can reverse disease phenotype...

Alternative Titles

Full title

Computational drug repurposing against SARS-CoV-2 reveals plasma membrane cholesterol depletion as key factor of antiviral drug activity

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_plos_journals_2665140023

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2665140023

Other Identifiers

ISSN

1553-7358,1553-734X

E-ISSN

1553-7358

DOI

10.1371/journal.pcbi.1010021

How to access this item